The p34 'x protein [p38 tax, p34, p38(XBL), XBL-I] of bovine leukaemia virus (BLV) activates transcription from the BLV long terminal repeat (LTR) promoter. To analyse the functional properties of this protein, inframe insertions and internal deletions were systematically introduced in a plasmid-encoded copy of the p34 t~X gene. The abilities of wild-type and mutant genes to activate gene expression from the LTR promoter linked to the chloramphenicol acetyltransferase gene and to inhibit trans-activation by the wild-type protein were studied. The trans-activating activity of 14 of the 18 mutants tested was completely abolished, but four mutants each containing a lesion in the internal portion of the polypeptide retained activity. Taken together, these results suggest the presence of an internal region of the polypeptide where structural integrity is less strictly required for the functional activity of this protein. Among the mutants incompetent in the transactivation assay, only two with mutations in the Nterminal region of the polypeptide inhibited transactivation by the wild-type protein in a dose-dependent manner. These results facilitate understanding of the physiological function of the tax protein family.
Bovine leukaemia virus (BLV) is a aetiological agent of lymphoproliferative diseases in cattle (Burny et al., 1980) . BLV and human T cell leukaemia viruses type I (HTLV-I) and type II (HTLV-II) constitute a unique retrovirus subfamily, particularly characterized by the presence of transcriptional and post-transcriptional regulator genes in their genomes. At least two types of regulator proteins, the tax (Slamon et al., 1984; Sagata et al., 1985a) and the rex (Inoue et al., 1986; Shima et al., 1986; Rice et al., 1987) proteins, are encoded by different but overlapping reading frames located between the env gene and the 3' long terminal repeat (LTR) sequence. The regulatory activities of these proteins are essential for efficient replication of the viruses (Itohara et al., 1988) . The tax protein of BLV, p34 taX, is a 34K nuclear protein that activates transcription from the BLV LTR promoter as well as from other cellular and viral promoters such as the c-fos gene promoter and the adenovirus E3 promoter (Rosen et al., 1986; Derse, 1987; Itohara et al., 1988; Katoh et al., 1989) . Katoh et al. (1989) suggested that the core DNA sequence within these promoters responsible for the trans-activation by p34 t~x is the consensus sequence proposed for a cAMPt Present address: Zen-noh Institute of Animal Health, 70hjama-chi, Sakura-shi, Chiba-ken 285, Japan.
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0001-0321 © 1991 SGM responsive element. Moreover, p34 tax has been suspected to be involved in BLV leukaemogenesis, and indeed it was recently shown that p34 ta~ transforms rat primary fibroblasts in cooperation with the Ha-ras oncogene product (Willems et aL, 1990) , although the relationship between this activity and the trans-activating activity of p34 tax is not understood. In a functional analysis of p34 tax, the trans-activating activity of all of the mutants encoded by p34 t~X genes containing site-directed deletions and in-phase linker insertions was shown to be abolished (Willems et aL, 1989) . This finding illustrates the narrow range of structural variations that allow full activity of p34 taX, although the number of mutants examined was limited.
In the present study, to obtain further insight into the functional properties of p34 tax, a large number of inphase linker insertion (LI) and short internal deletion mutations were introduced into a plasmid-encoded copy of the p34 t~x gene, and their effects on the functional activity of p34 t~× were determined.
Plasmid pRSVXI, designed for high level expression of p34 tax in mammalian cells, contains the coding sequence for p34 tax taken from an expression plasmid, pSVXI (Itohara et al., 1988) , and this sequence is linked to the Rous sarcoma virus RSV promoter and simian virus 40 (SV40) polyadenylation sequence derived from plasmid pRSVcat (Gorman et al., 1982a) . Reporter Short communication The amino acid modifications in these mutants deduced from nucleotide sequence data are shown, and the positions of amino acid residues flanking the modifications are indicated in parentheses. Activity of the mutants indicates the levels of CAT expression obtained with the mutants in the trans-activation assay described in the text, and normalized to the wt protein (wt) so that the level of CAT expression from pLTRcat in the presence of cotransfecting pRSVXI is set at 100%. Under the assay conditions, the level of CAT expression from pLTRcat in the absence of cotransfecting pRSVXI was 0.9~, and this background level is not subtracted from the figures with mutants.
plasmid pLTRcat for monitoring trans-activation of the BLV LTR promoter contains a BLV LTR promoter sequence between positions 8096 and 256 in the nucleotide numbering of Sagata et al. (1985b) that is linked to the chloramphenicol acetyltransferase (CAT) gene derived from pRSVcat. This BLV LTR sequence was taken from an infectious BLV DNA described by Itohara & Sekikawa (1987) . To generate LI mutants, pRSVXI was digested with various restriction enzymes as indicated in Fig. 1 , then blunt-ended with the Klenow polymerase, if necessary, and ligated with a linker of appropriate length to restore the reading frame. The linker DNAs employed were a 10-mer XhoI linker for LI-1, an 8-mer XhoI linker for LI-2 and LI-6, and a 12-mer XhoI linker for LI-3, LI-4 and LI-5. For constructing deletion-insertion (DI) mutants, plasmids pilE and pTA were made first. In pilE, the RSV promoter and the coding sequence for p34 tax were linked and cloned between the Sinai and XbaI sites of pUC18 and a 1-4 Kb foreign DNA was inserted at the PstI site of the vector. In addition, the SphI site in the polylinker sequence of the vector was converted to an XhoI site by linker ligation. In pTA, the coding sequence for p34 ta~ and the SV40 polyadenylation sequence were cloned together between the XbaI and SphI sites of pUC18 and a 1-5 kb foreign DNA was inserted at the SacI site of the vector. In addition, the EcoRI site in the polylinker sequence was changed into an XhoI site by linker ligation. The plasmids pilE and pTA were cut at the SalI and KpnI sites, respectively, in the polylinker sequence and digested with Bal 31 exonuclease. Then, after filling-in with T4 DNA polymerase, the digested plasmids were ligated with the 8-mer XhoI linker, and subsequently used to transform Escherichia coli cells to ampicillin resistance. Mutant genes were reconstructed from the complementary deletion sets by ligating appropriate inserts from XhoI-HindlI-restricted pTA derivatives into complementary XhoI-HindlII-restricted pilE derivatives. The nucleotide sequence at and around the linker in each of the LI and DI mutant plasmids was verified by sequence analysis on double-stranded plasmid DNA using synthetic oligonucleotide primers. The structure of each of the mutants is identical to that of pRSVXI except for the mutation site. Primary ovine embryonic (OE) cells (Itohara & Sekikawa, 1987) transfected with the expression plasmids were examined for expression of wild-type (wt) and mutant p34 tax proteins by immunoblot analysis using an antiserum directed against a synthetic decapeptide, LENEWLSRLF, which corresponds to the C terminus of p34 t"~. The results indicated that the wt and mutant proteins with the expected sizes (approximately 34K) were expressed in the transfected cells at levels comparable to each other (not shown).
Transcriptional activation of the BLV LTR promoter by wt p34 tax and its mutants was examined by cotransfection assay. OE cells (1.5 × 105) were cotransfected with pRSVXI and mutant plasmids (1-5 p-g) along with pLTRcat (1.0 ~tg) and pRSVGH (0-5 p.g), and the enzymic activity of CAT transiently expressed in the cells was measured 2 days after cotransfection as described by Gorman et al. (1982b) . Plasmid pRSVGH harbouring the human growth hormone gene was used in the transfections as an internal control for the efficiency of transfection (Sakurai & Strominger, 1988) . Under these conditions, the CAT expression from pLTRcat was enhanced 110-fold in the presence of cotransfecting pRSVXI, and similar levels of trans-activation were observed in NIH3T3 cells, CV-I cells and F9 cells (not shown). Cotransfection experiments using increasing amounts of pRSVXI showed that CAT expression directed by the LTR promoter was enhanced 30-fold even when only 0-8 ng of pRSVXI was present. The levels of CAT expression increased when the amount of pRSVXI DNA was increased to between 0.8 and 13 ng, and levelled out thereafter (not shown).
Results of the trans-activation assay with the mutants are shown in Fig. 1 along with amino acid modifications introduced in the mutants. First, many mutants, which include four of six LI mutants and 12 of 14 DI mutants, were shown to have no ability to trans-activate the LTR promoter, indicating that the integrity of the amino acid sequence in almost the entire region of the p34 tax protein is critical for the functional activity of this protein. In particular, the finding that LI-I, LI-3 and LI-5 containing linker insertions at ClaI, Bali and StuI sites exhibited no trans-activation is consistent with the data in the analysis by Willems et al. (1989) on mutants with linker insertions at the same sites despite the difference in linker DNA employed in the construction of the plasmids and thus in the amino acid sequence inserted into the polypeptide. Second, in addition to these incompetent mutants, mutants retaining the activity were obtained: LI-2, LI-4 and DI-9 had levels of the activity similar to the wt protein, and DI-10 showed a markedly reduced but distinct activity level. Amino acid modifications in these mutants were within the internal third of the polypeptide. In particular, the fact that mutations in LI-2, DI-9 and DI-10 retain the transactivating activity suggests that structural integrity is less strictly required in the region defined by these mutation sites (residues 95 to 147, see Fig. 1 ) for the functional activity of p34 t~ than in other regions. Wachsman et al. (1987) have shown that a mutant of the tax protein of HTLV-II inhibits trans-activation of the HTLV-II LTR promoter by the cognate wt protein in a trans-dominant manner. To determine whether the mutants incompetent in the trans-activation assay contained mutants with the analogous phenotype, they were tested for their ability to reduce the level of expression from pLTRcat in the presence of wt p34 tax. For this purpose, 1.5 × 105 OE cells were cotransfected with pRSVXI (3 ng), pLTRcat (1-0 p-g), pRSVGH (0.5 Bg) and mutant plasmids (1.5 p-g); then the CAT activity in the cells was measured. The level of CAT expression from pLTRcat in the presence of 3 ng pRSVXI had been shown to be approximately 80 ~ relative to the saturating level. Among the defective mutants, only DI-1 and DI-6 markedly suppressed CAT expression from pLTRcat in the presence of cotransfecting pRSVXI (Fig. 2) . In separate transfections, cotransfection with up to 1.5 ~tg of DI-I or DI-6 along with plasmid pURScat, which harbours the CAT gene linked to the RSV promoter, did not change the level of CAT expression from pURScat, indicating that the inhibition of expression by the mutants was due to the specific inhibition of transactivation, rather than to non-specific toxic effects of the mutants (not shown). The extent of inhibition by the mutants increased when the amounts of the mutant plasmids were increased (Fig. 2) . Fig. 2 . Inhibition by the dominant-negative mutants of p34t""-induced trans-activation. OE cells were cotransfected with indicated amounts of mutant plasmids DI-1 (O) and DI-6 (O) along with pLTRcat (1.0 lag), pRSVXI (3 ng), pRSVGH (0.5 lag) and appropriate amounts of plasmid pRSVlac; then CAT activity was measured as described in the text. pRSVlac was used in the transfections to keep the amount of transfecting DNA constant. The level of CAT expression obtained in the absence of the mutant plasmids is set at 100%.
These results indicate that DI-1 and DI-6 are mutants with dominant-negative phenotypes. Several mechanisms could account for the inhibition by these mutants. Briefly: (i) the mutants may associate with the wt protein to form multimers that are not able to trans-activate the promoter; (ii) they may compete with wt p34 'ax in the interaction with cellular proteins that are essential for the trans-activation; (iii) they may compete in the binding to the LTR promoter; (iv) mutations in these mutants may unmask autosuppressive activity that is normally present in, but not detected with, the wt protein. In any case, the finding that only DI-1 and DI-6 exhibit inhibitory activity indicates that the residual functional activity retained by these mutants that underlies the inhibition is also very sensitive to the effects of mutations as employed in this study. In DI-1, residue 10 is replaced by a tripeptide PRG. Of interest is that the mutant of the tax protein of HTLV-II that inhibits trans-activation by the wt protein has an amino acid change at residue 5 (Wachsman et al., 1987) . Taken together, these results suggest that the extreme N-terminal regions of these two structurally related proteins share a common function, and that the disruption of this function leads to the generation of mutants with dominant-negative phenotypes. In another dominant-negative mutant, DI-6, residues 78 and 79 are replaced by a tripeptide ASR. A recent mutational analysis of the tax protein of HTLV-I showed that missense mutations introduced in a region (residues 17 to 130) of the polypeptide frequently abolished the nuclear localization of this protein (Smith & Greene, 1990) . In this regard, it remains to be seen whether DI-6 and the other mutants with mutations in the corresponding region of the p34 tax polypeptide localize normally in the nucleus. Indirect immunofluorescence analysis using our antiserum was not successful.
Trans-dominant repressor mutants of viral regulatory proteins such as VP 16 of herpes simplex virus (Friedman et al., 1988) , the tat protein of human immunodeficiency virus (Green et al., 1989) and the rex protein of HTLV-I (Rimsky et al., 1989) have been shown to block the replication of the respective viruses, and these proteins are regarded as a new class of antiviral agents. In this connection, it would be interesting to test whether the dominant-negative mutants obtained in this study would block the intracellular replication of BLV.
